#antibody test coronavirus

[reasonsforhope]

Article | Paywall Free

"The Food and Drug Administration approved new mRNA coronavirus vaccines Thursday [August 22, 2024], clearing the way for shots manufactured by Pfizer-BioNTech and Moderna to start hitting pharmacy shelves and doctor’s offices within a week.

Health officials encourage annual vaccination against the coronavirus, similar to yearly flu shots. Everyone 6 months and older should receive a new vaccine, the Centers for Disease Control and Prevention recommends.

The FDA has yet to approve an updated vaccine from Novavax, which uses a more conventional vaccine development method but has faced financial challenges.

Our scientific understanding of coronavirus vaccines has evolved since they debuted in late 2020. Here’s what to know about the new vaccines.

Why are there new vaccines?

The coronavirus keeps evolving to overcome our immune defenses, and the shield offered by vaccines weakens over time. That’s why federal health officials want people to get an annual updated coronavirus vaccine designed to target the latest variants. They approve them for release in late summer or early fall to coincide with flu shots that Americans are already used to getting.

The underlying vaccine technology and manufacturing process are the same, but components change to account for how the virus morphs. The new vaccines target the KP.2 variant because most recent covid cases are caused by that strain or closely related ones...

Do the vaccines prevent infection?

You probably know by now that vaccinated people can still get covid. But the shots do offer some protection against infection, just not the kind of protection you get from highly effective vaccines for other diseases such as measles.

The 2023-2024 vaccine provided 54 percent increased protection against symptomatic covid infections, according to a CDC study of people who tested for the coronavirus at pharmacies during the first four months after that year’s shot was released...

A nasal vaccine could be better at stopping infections outright by increasing immunity where they take hold, and one is being studied in a trial sponsored by the National Institutes of Health.

If you really want to dodge covid, don’t rely on the vaccine alone and take other precautions such as masking or avoiding crowds...

Do the vaccines help prevent transmission?

You may remember from early coverage of coronavirus vaccines that it was unclear whether shots would reduce transmission. Now, scientists say the answer is yes — even if you’re actively shedding virus.

That’s because the vaccine creates antibodies that reduce the amount of virus entering your cells, limiting how much the virus can replicate and make you even sicker. When vaccination prevents symptoms such as coughing and sneezing, people expel fewer respiratory droplets carrying the virus. When it reduces the viral load in an infected person, people become less contagious.

That’s why Peter Hotez, a physician and co-director of the Texas Children’s Hospital Center for Vaccine Development, said he feels more comfortable in a crowded medical conference, where attendees are probably up to date on their vaccines, than in a crowded airport.

“By having so many vaccinated people, it’s decreasing the number of days you are shedding virus if you get a breakthrough infection, and it decreases the amount of virus you are shedding,” Hotez said.

Do vaccines prevent long covid?

While the threat of acute serious respiratory covid disease has faded, developing the lingering symptoms of “long covid” remains a concern for people who have had even mild cases. The CDC says vaccination is the “best available tool” to reduce the risk of long covid in children and adults. The exact mechanism is unclear, but experts theorize that vaccines help by reducing the severity of illness, which is a major risk factor for long covid.

When is the best time to get a new coronavirus vaccine?

It depends on your circumstances, including risk factors for severe disease, when you were last infected or vaccinated, and plans for the months ahead. It’s best to talk these issues through with a doctor.

If you are at high risk and have not recently been vaccinated or infected, you may want to get a shot as soon as possible while cases remain high. The summer wave has shown signs of peaking, but cases can still be elevated and take weeks to return to low levels. It’s hard to predict when a winter wave will begin....

Where do I find vaccines?

CVS said its expects to start administering them within days, and Walgreens said that it would start scheduling appointments to receive shots after Sept. 6 and that customers can walk in before then.

Availability at doctor’s offices might take longer. Finding shots for infants and toddlers could be more difficult because many pharmacies do not administer them and not every pediatrician’s office will stock them given low demand and limited storage space.

This year’s updated coronavirus vaccines are supposed to have a longer shelf life, which eases the financial pressures of stocking them.

The CDC plans to relaunch its vaccine locator when the new vaccines are widely available, and similar services are offered by Moderna and Pfizer."

-via The Washington Post, August 22, 2024

[pathologylab]

Feeling doubtful about your Covid like symptoms? #Genes2Me RT-PCR test can help put your mind at ease. With fast results and high #accuracy, It's the perfect #solution for detecting the presence of the #coronavirus. Safe, efficient, and trusted by #healthcare professionals, our #RT_PCR test is the go-to solution for #COVID detection. Get peace of mind with our reliable and dependable testing solution.

BOOK NOW!! www.rtpcrtest.com

For more details, Call us at 18001214030 or drop us an email at social@genes2me.com

#covid19 #pcr #rapidtest #selfcare #selftest #madeinindia #antibody #antigentest

[mariacallous]

For Sander van der Linden, misinformation is personal.

As a child in the Netherlands, the University of Cambridge social psychologist discovered that almost all of his mother’s family had been executed by the Nazis during the Second World War. He became absorbed by the question of how so many people came to support the ideas of someone like Adolf Hitler, and how they might be taught to resist such influence.

While studying psychology at graduate school in the mid-2010s, van der Linden came across the work of American researcher William McGuire. In the 1960s, stories of brainwashed prisoners-of-war during the Korean War had captured the zeitgeist, and McGuire developed a theory of how such indoctrination might be prevented. He wondered whether exposing soldiers to a weaker form of propaganda might have equipped them to fight off a full attack once they’d been captured. In the same way that army drills prepared them for combat, a pre-exposure to an attack on their beliefs could have prepared them against mind control. It would work, McGuire argued, as a cognitive immunizing agent against propaganda—a vaccine against brainwashing.

Traditional vaccines protect us by feeding us a weaker dose of pathogen, enabling our bodies’ immune defenses to take note of its appearance so we’re better equipped to fight the real thing when we encounter it. A psychological vaccine works much the same way: Give the brain a weakened hit of a misinformation-shaped virus, and the next time it encounters it in fully-fledged form, its “mental antibodies” remember it and can launch a defense.

Van der Linden wanted to build on McGuire’s theories and test the idea of psychological inoculation in the real world. His first study looked at how to combat climate change misinformation. At the time, a bogus petition was circulating on Facebook claiming there wasn’t enough scientific evidence to conclude that global warming was human-made, and boasting the signatures of 30,000 American scientists (on closer inspection, fake signatories included Geri Halliwell and the cast of M*A*S*H). Van der Linden and his team took a group of participants and warned them that there were politically motivated actors trying to deceive them—the phony petition in this case. Then they gave them a detailed takedown of the claims of the petition; they pointed out, for example, Geri Halliwell’s appearance on the list. When the participants were later exposed to the petition, van der Linden and his group found that people knew not to believe it.

The approach hinges on the idea that by the time we’ve been exposed to misinformation, it’s too late for debunking and fact-checking to have any meaningful effect, so you have to prepare people in advance—what van der Linden calls “prebunking.” An ounce of prevention is worth a pound of cure.

When he published the findings in 2016, van der Linden hadn’t anticipated that his work would be landing in the era of Donald Trump’s election, fake news, and post-truth; attention on his research from the media and governments exploded. Everyone wanted to know, how do you scale this up?

Van der Linden worked with game developers to create an online choose-your-own-adventure game called Bad News, where players can try their hand at writing and spreading misinformation. Much like a broadly protective vaccine, if you show people the tactics used to spread fake news, it fortifies their inbuilt bullshit detectors.

But social media companies were still hesitant to get on board; correcting misinformation and being the arbiters of truth is not part of their core business model. Then people in China started getting sick with a mysterious flulike illness.

The coronavirus pandemic propelled the threat of misinformation to dizzying new heights. Van der Linden began working with the British government and bodies like the World Health Organization and the United Nations to create a more streamlined version of the game specifically revolving around Covid, which they called GoViral! They created more versions, including one for the 2020 US presidential election, and another to prevent extremist recruitment in the Middle East. Slowly, Silicon Valley came around.

A collaboration with Google has resulted in a campaign on YouTube in which the platform plays clips in the ad section before the video starts, warning viewers about misinformation tropes like scapegoating and false dichotomies and drawing examples from Family Guy and Star Wars. A study with 20,000 participants found that people who viewed the ads were better able to spot manipulation tactics; the feature is now being rolled out to hundreds of millions of people in Europe.

Van der Linden understands that working with social media companies, who have historically been reluctant to censor disinformation, is a double-edged sword. But, at the same time, they’re the de facto guardians of the online flow of information, he says, “and so if we’re going to scale the solution, we need their cooperation.” (A downside is that they often work in unpredictable ways. Elon Musk fired the entire team who was working on pre-bunking at Twitter when he became CEO, for instance.)

This year, van der Linden wrote a book on his research, titled Foolproof: Why We Fall for Misinformation and How to Build Immunity. Ultimately, he hopes this isn’t a tool that stays under the thumb of third-party companies; his dream is for people to inoculate one another. It could go like this: You see a false narrative gaining traction on social media, you then warn your parents or your neighbor about it, and they’ll be pre-bunked when they encounter it. “This should be a tool that’s for the people, by the people,” van der Linden says.

[covid-safer-hotties]

Also preserved on our archive

By Benjamin Mateus

The ninth wave of the COVID-19 pandemic in the United States is finally receding, with estimated daily new infections based on wastewater data now standing at 669,000 per day, down from the August peaks of over 1.3 million. However, experts predict that the tenth wave will begin in late fall and continue through the winter holidays, as has taken place every year of the pandemic so far.

With one in 70 individuals currently infectious, the risk of coming into contact with someone in a classroom, work, or dining at a local facility with 25 to 50 people is considerable. And despite the relative lull in cases, there is more COVID-19 transmission now than during 56.1 percent of the pandemic. In other words, the “forever COVID” policy essentially means that COVID is now everywhere all the time.

Under these conditions, forced upon society by the capitalist ruling class, repeat infections act like a battering ram, taking a growing toll on the foundation of everyone’s overall wellbeing. There is a growing body of evidence that each hit weakens the organ systems, aging them biologically beyond the person’s stated age until sufficient injury begins to manifest in physically measurable symptoms.

At present, more than one billion cumulative COVID infections have occurred in the US, at a rate of around one per year per person, with somewhere between 3-4 infections on average among the entire population. Estimates place the number of Long COVID cases at over 410 million globally in just the first four years of the pandemic, while excess deaths are nearing 30 million.

Clearly, the pandemic is ongoing and remains a significant health risk for the global population. The criminality of the “forever COVID” policy is highlighted by the fact that virtually no funding is allocated to the development of next-generation mucosal vaccines, improved treatments during the acute phase of infection, or any treatments for Long COVID patients. While trillions are squandered on war and bank bailouts for the rich, nothing is provided for critical life-saving research.

Last week, results from the first clinical trial of a mucosal vaccine were released, showing remarkable levels of efficacy after a second dose.

The important study published by Chinese investigators demonstrated that an intranasally administered anti-COVID vaccine can induce robust mucosal immunity against the coronavirus in human subjects (128 healthcare workers). The study found that the vaccine provided substantial immune protection against COVID while demonstrating safety and tolerance.

Esteemed clinical researcher Dr. Eric Topol wrote on Twitter/X, “[two] doses of a COVID nasal vaccine spray led to more than a 50-fold increase in spike specific secretory IgA antibodies against 10 strains of SARS-CoV-2, indicative of potent mucosal immunity.” Furthermore, Topol added, “At least 86.2 percent of participants who completed two nasal vaccines doses maintained uninfected status, likely without even asymptomatic infection, for at least three months.”

Emergency room physician and indoor air quality proponent, Dr. Kashif Pirzada, replied, “This could potentially give a real ending to the pandemic. No more waves of illness, no more rushing for tests and antivirals if you’re elderly or vulnerable. Hope this comes out soon!”

However, large Phase 3 clinical trials are costly, requiring multiple participants to obtain statistically relevant information on clinical endpoints, not to speak of the research and development investment to identify a therapeutic that can be tested. Thus, under capitalism, there is virtually no investment in these large-scale trials and nothing is being done beyond offering boosters of the current vaccine, despite their greatly reduced efficacy in preventing transmission.

The mucosal vaccine study was conducted just as Chinese officials acquiesced to the demands of the imperialist powers to abandon their life-saving Zero-COVID public health program, resulting in the infection of virtually the entire population and the deaths of 1-2 million people. What could such a vaccine have meant to these millions that perished needlessly and the millions more globally since then?

This raises the broader question of why the international community, facing a devastating pandemic, could not bring its accumulated scientific bodies to address the need to develop a preventative treatment against COVID?

As a trigger event in world history, the COVID-19 pandemic has only accelerated and exposed the deep-seated contradictions in global capitalism, which demands the accumulation of profits at any costs. The ruling class has nothing but contempt for workers, refusing to invest in any social programs that can improve the lives of masses of people. Short sightedness, corruption, mistrust, and suspicion epitomize their actions, which are rapidly progressing to a world conflagration carrying the danger of nuclear war.

Simply put, the ruling class cares not one iota about mucosal vaccines, just as they harbor resentment against any public health policy that infringes on their ability to conduct business.

Refusing to invest in these life-saving technologies, the capitalist ruling class has condemned humanity to face a lifetime of reinfections with COVID-19. What are the implications of this criminal policy?

Multiple previous studies have highlighted the dangers posed by reinfections with SARS-CoV-2. A recent study uploaded as a pre-print publication on Research Square (under review with the journal Nature Portfolio) by the Patient-Led Collaborative has once again found similar results when attempting to characterize the association between reinfections and the chronic debilitating condition known as Long COVID.

Among 3,382 participants (22 percent never had COVID, 42 percent with one prior infection and 35 percent with two or more infections), the risk of Long COVID was 2.14 times more likely among those with two COVID infections and 3.75 times more likely among those who had three or more COVID Infections compared to just one. Limitations in physical functioning measured in their study included ability to dress, bathe, perform moderate activities like vacuuming and functioning socially. Reinfections led to poorer overall health and worse immune health, including more severe outcomes and longer recovery from other infections.

As the authors wrote:

"Relative to those who did not report infections or experienced COVID-19 once, reinfections were associated with increased likelihood of severe fatigue, post-exertional malaise, decreased physical function, poorer immune health, symptom exacerbation before menstruation, and multiple other Long COVID symptoms. While vaccinations and boosters prior to infection are associated with lower likelihood of Long COVID, reinfections diminish their protective effect. The probability of reporting Long COVID remission is generally low (11.5 percent to 6.5 percent."

Another interesting finding of the study, which underscores the complete abandonment of public health efforts regarding COVID, is that a tiny number of those infected were prescribed antivirals during their acute COVID infections. Those with reinfections were also less likely to test, as the “forever COVID” policy has inured people from taking any protective measures to prevent infections.

The current alphabet soup of COVID strains is sees KP.3.1.1 dominate across the US and Europe, accounting for nearly 60 percent of all strains. However, a new variant known as XEC that was first detected in Germany in June has spread to more than 27 countries and accounts for six percent of all recently sequenced SARS-CoV-2 viruses in the US. Virologists expect this strain, derived from JN.1 through a complex recombination event and which has nearly twice the growth advantage, to overtake KP.3.1.1 and be the dominant variant during the winter season.

In a COVID update by TACT [Together Against COVID Transmission], the authors explain the dangers posed by these evolutionary developments of the SARS-CoV-2 viruses, writing:

"These variants can evade much of the immune responses from both vaccines and recent infections. Since they can evade antibodies to earlier variants, then that raises the risk of organ damage, vascular and neurological dysfunction, brain damage, and persistent infections which often leads to Long COVID. The unmitigated spread is raising concerns about their impact in the coming months."

Hospitalization rates for those 65 years and older and children were one of the highest during the summer from COVID and remain on par with the prior year’s summer/fall wave. The number of people that died from COVID In the week ending August 31, 2024, has climbed to 1,239, four times higher than the lows seen in June. At the present rate, it is expected that at least 60,000 people will officially lose their lives from acute COVID this year, not including deaths incorrectly attributed to another cause or due to the impact on the population’s health from accumulated infections.

These are not incidental and speculative issues. In a provocative report released by the Swiss Re Group, titled “The future of excess mortality after COVID-19,” one of the world’s leading providers of reinsurance and insurance, who specialize in financing the risk of death, they said, “[If] the ongoing impact of the disease is not curtailed, excess mortality rates in the general population may remain up to three percent higher then pre-pandemic levels in the US and 2.5 percent in the UK by 2033.”

They advised their investors:

"Based on current medical trends and expected advancements, we conclude that COVID-19 is still driving excess mortality both directly and indirectly. In the long term, lifestyle factors that contribute to poor metabolic health and lead to obesity and diabetes may become another compounding factor in population excess mortality. Insurers may wish to continue to monitor excess mortality and its underlying drivers in the general population closely, as well as the differences between general and insured populations."

[female-malice]

(archive)

For Sander Van der Linden, misinformation is personal.

As a child in the Netherlands, the University of Cambridge social psychologist discovered that almost all of his mother’s family had been executed by the Nazis during the Second World War. He became absorbed by the question of how so many people came to support the ideas of someone like Adolf Hitler, and how they might be taught to resist such influence.

While studying psychology at graduate school in the mid-2010s, van der Linden came across the work of American researcher William McGuire. In the 1960s, stories of brainwashed prisoners-of-war during the Korean War had captured the zeitgeist, and McGuire developed a theory of how such indoctrination might be prevented. He wondered whether exposing soldiers to a weaker form of propaganda might have equipped them to fight off a full attack once they’d been captured. In the same way that army drills prepared them for combat, a pre-exposure to an attack on their beliefs could have prepared them against mind control. It would work, McGuire argued, as a cognitive immunizing agent against propaganda—a vaccine against brainwashing.

Traditional vaccines protect us by feeding us a weaker dose of pathogen, enabling our bodies’ immune defenses to take note of its appearance so we’re better equipped to fight the real thing when we encounter it. A psychological vaccine works much the same way: Give the brain a weakened hit of a misinformation-shaped virus, and the next time it encounters it in fully-fledged form, its “mental antibodies” remember it and can launch a defense.

Van der Linden wanted to build on McGuire’s theories and test the idea of psychological inoculation in the real world. His first study looked at how to combat climate change misinformation. At the time, a bogus petition was circulating on Facebook claiming there wasn’t enough scientific evidence to conclude that global warming was human-made, and boasting the signatures of 30,000 American scientists (on closer inspection, fake signatories included Geri Halliwell and the cast of M*A*S*H).

Van der Linden and his team took a group of participants and warned them that there were politically motivated actors trying to deceive them—the phony petition in this case. Then they gave them a detailed takedown of the claims of the petition; they pointed out, for example, Geri Halliwell’s appearance on the list. When the participants were later exposed to the petition, van der Linden and his group found that people knew not to believe it.

The approach hinges on the idea that by the time we’ve been exposed to misinformation, it’s too late for debunking and fact-checking to have any meaningful effect, so you have to prepare people in advance—what van der Linden calls “prebunking.” An ounce of prevention is worth a pound of cure.

When he published the findings in 2016, van der Linden hadn’t anticipated that his work would be landing in the era of Donald Trump’s election, fake news, and post-truth; attention on his research from the media and governments exploded. Everyone wanted to know, how do you scale this up?

Van der Linden worked with game developers to create an online choose-your-own-adventure game called Bad News, where players can try their hand at writing and spreading misinformation. Much like a broadly protective vaccine, if you show people the tactics used to spread fake news, it fortifies their inbuilt bullshit detectors.

But social media companies were still hesitant to get on board; correcting misinformation and being the arbiters of truth is not part of their core business model. Then people in China started getting sick with a mysterious flulike illness.

The coronavirus pandemic propelled the threat of misinformation to dizzying new heights. Van der Linden began working with the British government and bodies like the World Health Organization and the United Nations to create a more streamlined version of the game specifically revolving around Covid, which they called GoViral! They created more versions, including one for the 2020 US presidential election, and another to prevent extremist recruitment in the Middle East. Slowly, Silicon Valley came around.

A collaboration with Google has resulted in a campaign on YouTube in which the platform plays clips in the ad section before the video starts, warning viewers about misinformation tropes like scapegoating and false dichotomies and drawing examples from Family Guy and Star Wars. A study with 20,000 participants found that people who viewed the ads were better able to spot manipulation tactics; the feature is now being rolled out to hundreds of millions of people in Europe.

Van der Linden understands that working with social media companies, who have historically been reluctant to censor disinformation, is a double-edged sword. But, at the same time, they’re the de facto guardians of the online flow of information, he says, “and so if we’re going to scale the solution, we need their cooperation.” (A downside is that they often work in unpredictable ways. Elon Musk fired the entire team who was working on pre-bunking at Twitter when he became CEO, for instance.)

This year, van der Linden wrote a book on his research, titled Foolproof: Why We Fall for Misinformation and How to Build Immunity. Ultimately, he hopes this isn’t a tool that stays under the thumb of third-party companies; his dream is for people to inoculate one another. It could go like this: You see a false narrative gaining traction on social media, you then warn your parents or your neighbor about it, and they’ll be pre-bunked when they encounter it. “This should be a tool that’s for the people, by the people,” van der Linden says.

–

Everyone needs to play this game.

[darkmaga-returns]

By Peter A. McCullough, MD, MPH

Total antibodies against the SARS-CoV-2 Spike protein is one of the most frequently ordered laboratory tests over the pandemic years. We have learned with mild infection there is a transient rise and fall in the antibody levels over three to six months yet there is durable immune memory and robust natural immunity if the body recognizes another SARS-CoV-2 infection. Once a person has had either the Delta or Omicron strain, there is zero chance of hospitalization or death due to the next COVID-19 illness as shown by Chin et al, 2022.

Recently, Majdoubi et al in collaboration with Drs Steven Pelech and Christopher Shaw, both professors and authors in Vancouver, BC, have demonstrated that most people had prior exposure to one of the beta coronaviruses that cause the common cold early in 2020. Thus their baseline cross-immunity played some role in protection. Please enjoy this comprehensive interview with two experts on COVID-19, antibodies, and so much more. They will introduce their wonderful published resource: Down the COVID-19 Rabbit Hole: Independent Scientists and Physicians Unmask the Pandemic.

[ammg-old2]

People struggling with “long Covid,” or the persistence of symptoms after an initial Covid-19 infection, can face cognitive difficulties such as “brain fog” and memory problems. Now, a study finds the severity of these symptoms is comparable to the brain aging ten years.

By testing the mental speed and accuracy of participants who had and had not been diagnosed with Covid-19, researchers found the cognitive decline was worst for people who had experienced Covid symptoms for more than 12 weeks, according to a study published this month in eClinicalMedicine, a journal published by The Lancet.

“The fact remains that two years on from their first infection, some people don’t feel fully recovered, and their lives continue to be impacted by the long-term effects of the coronavirus,” Claire Steves, a co-author of the study who researches aging and mental health at King’s College London, says in a statement.

Since the Covid-19 pandemic’s early days, scientists have raced to understand the symptoms associated with long Covid, such as depression, major fatigue, brain fog and even dementia.

In 2020, a separate team of researchers examined the brains of people who had died from Covid-19 and discovered their blood vessels, which were covered with antibodies, had sustained significant damage, reports Time’s Jamie Ducharme. The scientists concluded the virus had somehow caused the body’s immune system to attack its blood vessels, leading to inflammation in the brain.

It’s not clear whether this inflammation is the cause of brain fog and cognitive difficulties in living patients with long Covid, but Lara Jehi, a researcher at the Cleveland Clinic who was not involved in the current study or the 2020 research, tells Time she’s seen it impact both people with long Covid and Alzheimer’s disease. “We found many areas of overlap between the two, and these areas of overlap centered on…inflammation in the brain and microscopic injuries to the blood vessels,” she tells the publication.

To better understand long Covid’s effect on the brain, the new study put more than 3,000 participants through 12 different types of cognitive tests designed to measure memory, processing speed, attention, motor control and other thinking skills. A little over half of the participants had previously tested positive for Covid-19, and all were recruited through the Covid Symptom Study Biobank smartphone app.

In the first round of testing in 2021, researchers found the cognitive impairment associated with long Covid was clear, comparable to the brain being under “mild or moderate symptoms of psychological distress,” or ten years of aging, write the authors in the paper. During the second round of testing, which took place in 2022, patients showed no significant improvement. At that point, some participants’ cognitive decline had lasted nearly two years after infection.

The positive takeaway? Once a person’s Covid symptoms disappeared—regardless of whether they had persisted for three months or one week—their cognitive function appeared to recover.

This, at least, is “good news,” says Nathan Cheetham, a senior postdoctoral data scientist at King’s College London and study co-author, in the statement.

“This study shows the need to monitor those people whose brain function is most affected by Covid-19, to see how their cognitive symptoms continue to develop and provide support toward recovery,” he says in the statement.

About 15 percent of U.S. adults have experienced long Covid, according to the Household Pulse Survey by the National Center for Health Statistics. In the United Kingdom, about two million adults were impacted by the persistent condition as of January 2023, reports the Guardian’s Geneva Abdul.

Steves calls for more research into how long Covid victims can be aided in their recovery process, especially those who have been living with the symptoms for years.

“We need more work to understand why this is the case and what can be done to help,” she says in the statement.

[mediaexposed]

So here are links you must know. These links are straight up real websites from them.

Must look up

Cybernetics

Transhumanism

V MAT 1 and 2 genes otherwise known as god genes.

Transhumanism from UK government altering DNA. Bible says iron (tech) and clay (humans) shall not mix:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/986301/Human_Augmentation_SIP_access2.pdf

Luciferase enzyme:

https://www.fda.gov/vaccines-blood-biologics/science-research-biologics/luciferase-immunoprecipitation-system-lips-assay-rapid-simple-and-sensitive-test-detect-antibody

Event 201 a real pandemic exercise done in October 2019 few months before covid (Notice the alliances: bill gates and John Hopkins

https://www.centerforhealthsecurity.org/event201/

John Hopkins theragrippers on swabs:

https://hub.jhu.edu/2020/11/25/theragripper-gi-tract-medicine-delivery/

ID2020 (their 2020 vision) for digital implant. Look at alliances bill gates and Rockefeller

http://id2020.org

Reverse transcriptase on this vaccine will alter DNA: https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1.full.pdf

V mat 2 and v mat 1

These two genes are referred to as God gene 🧬

These genes have to do with Serotonin and mood genes like happy hormones

These genes more expressed in ppl that are more religious

They are targeting these genes to regulate to alter moods too

The scientists realized it’s kinda like computer like one shuts it down one starts it up

It’s mass mind control

Revelations says many people will be deceived and huge deception

Almost like removing free will making ppl robotic to be more subject to obeying

1.) Human altered DNA by Supreme Court patented 2013:

https://www.supremecourt.gov/opinions/12pdf/12-398_1b7d.pdf

2.) Covid 19 testing patented by Rothschild 2015:

https://pubchem.ncbi.nlm.nih.gov/patent/US-2020279585-A1

3.) ID patent for virus pathogen

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11,107,588.PN.&OS=PN/11,107,588&RS=PN/11,107,588

4.) Human coronavirus patent that expires in 2024

https://patents.google.com/patent/US7220852B1/en

5.) Cryptocurrency (note the 666 and made by Microsoft/gates) using human body patent:

https://patents.google.com/patent/WO2020060606A1/en

6.) Nano particles and quantum dot to bind with human peptide in body patent:

https://patents.google.com/patent/US8378075

7.) Vaccine Nanotechnology (confirmed nanotechnology is in these mRNA vaccines) patent:

https://patents.google.com/patent/EP2630967A1/es

8.) Moderna vaccine patents. If you read through there’s definitely mention of altered DNA through cDNA and it compares human DNA sequence

https://www.modernatx.com/patents

There’s way more patents. These are just some important ones to look at.

Connect the dots.

Supreme Court has a patent saying cDNA is not natural and is patented.

Definition on science direct: Complementary DNA (cDNA) is a DNA copy of a messenger RNA (mRNA) molecule produced by reverse transcriptase, a DNA polymerase that can use either DNA or RNA as a template.

Scientific article proving mRNA vaccines through reverse transcriptase that it can totally alter your naturally occurring original DNA.

https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1.full.pdf

Now look at the Patents for the Moderna vaccine. They talk about cDNA. https://www.modernatx.com/en-US/patents

They’re def messing with peoples DNA 🧬 this is satanic cause we’re made in Gods image.

https://youtu.be/_uqPEd_503A

[homehealthcarehub101]

Home PCR Tests: A Closer Look at the PCR Test At Home Dubai Option

The COVID-19 pandemic sparked major growth in the development and usage of diagnostic and antibody tests that patients can self-administer from home. Home PCR tests in particular enable private, convenient detection of active coronavirus infections. For those wondering whether accurate PCR Test At Home Dubai kits are available, exploring the leading options provides helpful guidance.

How Do Home PCR Tests for COVID-19 Work?

The PCR (polymerase chain reaction) technique is the gold standard for directly detecting the presence of the COVID-19 virus from respiratory samples. Home PCR test kits allow patients to collect their own nasal or saliva samples and perform the PCR assay without visiting a clinic.

PCR tests work by identifying the specific genetic material of the COVID-19 virus. Users collect a sample, mix it with chemical reagents, and insert the solution into the test kit for analysis. Results are displayed indicating whether viral genetic material was detected based on any color change reaction on the test strips.

Kits include step-by-step instructions to ensure patients perform the easy, quick tests properly using non-invasive nasal swabs or saliva collection. Many provide results within 10-30 minutes.

Here is a video from MedCram Youtube Channel about At Home Rapid COVID 19 Tests and False Positives (Coronavirus Antigen Tests). Watch the video

Benefits of At-Home PCR Testing

Here are some of the major advantages of having access to accurate home PCR tests for COVID-19:

Convenience: Test from the privacy of your residence without traveling to clinics.

Speed: Get results rapidly within minutes rather than waiting days for lab tests.

Self-Administered: Users can collect their own sample comfortably rather than relying on technicians.

Affordability: Individual kits are very competitively priced.

Detection Reliability: PCR technology directly identifies viral presence with high accuracy.

Ease of Use: Tests have simple, straightforward instructions for patients of all ages.

Infection Verification: Confirms active infections unlike antibody tests.

Having the option to privately, quickly, and accurately test for possible COVID-19 infections at home provides significant peace of mind during the pandemic.

How Reliable Are Home PCR Tests?

Many people reasonably wonder whether DIY home PCR test kits can match the reliability of lab-based PCR tests. The good news is that leading home PCR kits on the market have very high accuracy.

Most kits have published sensitivity and specificity above 90% when compared to lab PCR tests. High quality home tests analyze samples using comparable PCR methodology and match labs in detecting positives and negatives.

Furthermore, unlike Rapid PCR Test At Home kits some vendors offer, full home PCR tests analyze the sample through many amplification cycles to maximize accuracy. With good sampling collection, top home PCR kits offer laboratory-grade results conveniently at home.

Leading Home PCR Test Kit Options

For those exploring PCR Test At Home Dubai choices, here are some of the top-rated home PCR kits to consider:

Cue Health PCR Test: Cue offers an FDA-authorized home PCR test delivering highly accurate results in 20 minutes with nasal swab samples.

Lucira Check It PCR Test: This is a single-use PCR kit with 98% validated accuracy that provides molecular-level detection from nasal samples in 30 minutes or less.

Ellume COVID-19 Home Test: This over-the-counter home kit uses a mid-turbinate nasal sample and provides an amplified PCR digital reading of positive or negative in 15 minutes on a connected analyzer.

Pixel by LabCorp PCR Test: Pixel is a monitored at-home nasal PCR test analyzed through LabCorp with over 98% accuracy returning results within 1-2 days.

Doximity's Covid-19 PCR Test: Doximity partners with qualified labs for monitored video-observed PCR testing with 97%+ accuracy and results in 24 hours.

All these options allow for convenient, accurate at-home COVID-19 testing using PCR with trusted partners. Kits can be purchased online and shipped directly to your home in Dubai.

When Are Home PCR Tests Recommended?

The CDC recommends utilizing home PCR tests in situations such as:

If you have any symptoms of COVID-19. Home testing allows quick confirmation.

After exposure events to quickly check for possible infection.

Before visiting individuals at higher risk for severe illness.

Before travel or group events for added assurance.

For frequent screening in schools or workplaces.

Even fully vaccinated individuals should test if they experience COVID-like symptoms or have a known exposure. Home PCR tests make quick detection fast and easy.

Home PCR Tests Offer Accuracy and Convenience

High quality Home PCR Tests have become an important tool in the fight against COVID by making reliable diagnostic testing accessible outside of clinics. There are excellent PCR Test At Home Dubai options available matching the standards of lab PCR sensitivity and specificity. Home PCR kits allow people to conveniently and confidently check themselves for possible COVID-19 infections from the privacy of home. As the technology continues advancing, home collection PCR will likely take on an increasingly vital role supporting public health and safety.

[rehsgalleries]

At Rehs Contemporary Galleries - Josh Tiessen – Vanitas and Viriditas. On view from April 28th through May 26th

The Ferret Trials

Oil on panel

12 x 12 inches

$4,000.00

https://rehs.com/Josh_Tiessen_The_Ferret_Trials.html

In my painting, a lone ferret lays deceased on a lab table with a syringe––perhaps one of the many experimental injections for risky gain-of-function research. This work is a lament for the atrocities of vivisection (animal testing). The seven rose petals are symbolic of a funeral. It is my way of eulogizing the Black-Footed Ferret, the most commonly used species for coronavirus vaccine experiments, due to its lung structure resembling that of humans. While at first ferrets showed promising signs of antibody response, many died later when exposed to the wild virus [iii]. Today, animals are experimented on in labs all over the world, and, as a result, just like the ferrets, many of them prematurely perish due to compromised immune systems.

[didanawisgi]

Why does it take that long?

GEERT VANDEN BOSSCHE

"'Does Geert Vanden Bossche actually know what he’s talking about, or does he just have a bit too much phantasy? Earlier this year, he claimed that a more virulent coronavirus would emerge in highly COVID-19 (C-19) vaccinated countries by the end of June, but - once again - he has misjudged that timeline. Can we still take that man seriously? Or is this just a miscalculation of at most a few weeks, and will his predictions still come true this summer?

If his predictions still hold true, why does it take so long for mutations leading to increased viral virulence to be naturally selected?'

We may have overlooked a crucial aspect of viral transmission, namely the post-exposure replication and spread of the virus within the upper respiratory tract (URT)! In C-19 vaccinees, viral replication and spread within the URT is negatively impacted by the adsorption of more infectious progeny virus on the surface of dendritic cells (DCs) patrolling the URT (see Fig. 1 below). Virus adsorption onto DCs reduces the number of infectious viral particles available to infect new target epithelial cells within the URT. The ratio of infectious virus particles to the number of target cells present in a defined space (e.g., the URT) is called the ‘multiplicity of infection’ (MOI). As explained below, understanding MOI helps in interpreting the replication dynamics of infectious agents.

A low MOI is thought to promote natural selection of more infectious variants. However, the cytokine environment created by more infectious SARS-CoV-2 (SC-2) variants causes more progeny virus to adsorb onto the surface of URT-patrolling DCs. Hence, the higher intrinsic infectiousness of newly emerging variants will not lead to a proportional increase in the number of newly produced viral particles available for productive infection of epithelial target cells in the URT of virus-exposed C-19 vaccinees. Since this leads to a reduced rate of viral shedding in the URT, the viral load transmitted through direct contact with asymptomatically or mildly infected C-19 vaccinees will be relatively low. As a result, the MOI in directly exposed individuals will also be reduced.

Consequently, re-exposure to newly emerging SC-2 variants keeps the MOI of epithelial target cells in the URT of C-19 vaccinees low, despite the increased infectiousness of these lineages. This repeatedly compromises the productivity of viral inter-host transmission[1] much more than it affects its efficiency. In other words, lower MOIs associated with more infectious variants keep productive viral infection rates in the URT low while (asymptomatically or mildly) infected individuals can transmit the virus for a prolonged period, thereby ensuring efficient inter-host transmission.  

As vaccine breakthrough infections (VBTIs) with more infectious variants come with lower MOIs, the rate of viral adsorption onto URT-patrolling dendritic cells (DCs) will be lowered too, decreasing the binding of (polyreactive) non-neutralizing antibodies (PNNAbs) to DC-tethered virions. It follows that the successive emergence of more infectious variants in highly C-19 vaccinated regions (as depicted in Fig. 4 below) could explain why, despite a substantial increase in the estimated infection rate (see Fig. 2 and % test positivity in Fig. 3) and wastewater activity, ongoing VBTIs will only result in a rather slow increase in collective immune pressure on viral transinfection[2]. As a result, it requires more time for nature to select lineages that have accumulated the necessary mutations and adaptations that lead to increased virulence. Hence, in the majority of people from highly C-19 vaccinated populations, respiratory symptoms and shedding at the URT are still relatively mild, whereas population-level immune pressure on PNNAb-mediated viral inhibition is slowlyincreasing due to the gradually decreasing binding of PNNAbs to DC-tethered virions. Reduced binding of these virulence-inhibiting antibodies may explain the current uptick in C-19 hospitalization and death rates (see Fig. 3 below).

Just like in a natural pandemic, we are currently dealing with high virus transmission rates and an increasing number of severe C-19 disease cases. However, whereas in a natural SC-2 pandemic the number of severe cases typically decreases as herd immunity controls virus transmission, the current expectation is that the number of severe cases of disease will only escalate because herd immunity does not develop during an immune escape pandemic, and thus virus transmission continues unchecked and rampant!

This is why I keep saying that societies in highly C-19 vaccinated regions will be caught off guard!

Last but not least, it is interesting to note that newly emerging (sub)variants are increasingly acquiring glycan-based mutations on the N-terminal domain of the spike protein (S-NTD; see: https://x.com/LongDesertTrain/status/1814839721182257211). As previously anticipated (https://www.voiceforscienceandsolidarity.org/scientific-blog/predictions-gvb-on-evolution-c-19-pandemic), this suggests that nature is now favoring glycan-based mutations as a strategy to counteract the suboptimal immune pressure exerted by trans infection-inhibiting PNNAbs (which target a conserved antigenic site within S-NTD) in C-19 vaccinees. These mutations are thought to cause steric hindrance that impedes the binding of PNNAbs to the conserved antigenic site on S-NTD. Once glycan-based mutations become increasingly incorporated into circulating variants, it is highly likely that the virus will largely rely on these mutations to evade the population-level immune pressure affecting its virulence. It's therefore fair to conclude that we're not yet out of the woods!"

[covid-safer-hotties]

preserved in our archive

By Jason Gale

Hi, it’s Jason in Melbourne. Almost five years after Covid‑19 broke out, scientists are still unraveling its pathological modus operandi. Before I get into that...

Toxic blood effects Clotting disorders in Covid patients were spotted by researchers in China in early 2020, but the true extent of the risk only became clear when even patients with mild respiratory symptoms began experiencing strokes.

At first, doctors suspected these clots might result from a “cytokine storm” — an intense immune response releasing a surge of inflammation-signaling proteins. Others noted that the virus could directly damage blood vessel linings.

But Katerina Akassoglou, a neurovascular brain immunologist at the Gladstone Institutes and UC San Francisco, wasn’t convinced that the virus itself wasn’t a cause.

Navigating social distancing requirements that complicated lab work, Akassoglou and her collaborators conducted a series of experiments in mice to explore the pernicious role of the coronavirus’s spike protein.

They discovered that beyond serving as the virus’s “key” to enter cells, spike binds with a blood clotting factor called fibrinogen, creating structurally abnormal, inflammation-promoting clumps of fibrin — the insoluble material that forms the mesh-like structures essential for wound healing.

High levels of these abnormal clots not only push the body’s clotting system into overdrive, increasing clot formation and inflammation, but also suppress natural killer cells — the immune system’s virus-clearing soldiers.

When this damaging cycle occurs alongside a breakdown in the protective layer of cells around the brain’s blood vessels, toxins and bloodborne proteins, including fibrin, can seep into the body’s most vital organ. Once there, these substances activate microglia — the brain’s immune cells —which begin attacking healthy brain cells, contributing to the neurological symptoms of long Covid.

Akassoglou had been studying this damaging cascade for decades in patients with Alzheimer’s disease and multiple sclerosis. Still, until SARS-CoV-2 came along, she had no idea it could be triggered by a viral infection.

“For some reason, this virus has evolved to interfere with the coagulation system in a way that other viruses do not,” she told me. Fibrin’s role in driving toxic inflammation is common in many diseases, but “in the presence of spike, it gets a lot worse.”

In experiments with mice lacking fibrinogen, Covid leads to much less inflammation, and the infection clears faster. “Studies suggest that if you deplete fibrin, inflammation improves, no matter what initially triggers it.”

Although Akassoglou’s focus has been on the brain, she’s hopeful this research will be expanded to understand the effects on the heart, liver, kidneys, and gastrointestinal tract.

In the meantime, she’s developing a way to halt this damaging reaction. A first-in-class antibody treatment designed to specifically block fibrin’s toxic effects entered early-stage patient studies in May, with no reported safety concerns so far.

Results are expected next year and could lead to more advanced clinical trials to test the immunotherapy’s potential to treat not only long Covid but also other serious diseases like multiple sclerosis and Alzheimer’s.

[helthcareheven]

Poultry Pathology Perspectives: Insights from Diagnostics

Introduction to Poultry Diagnostics

Poultry diagnostic refers to the identification and analysis of diseases and health issues affecting poultry flocks. Proper diagnostics is crucial for poultry producers to maintain flock health and productivity. This article will explore some key aspects of poultry diagnostic including types of testing, sample collection, common diseases, and the role diagnostics plays in disease prevention and treatment. Types of Diagnostic Testing

There are several types of diagnostic tests that can be used to determine the health status of poultry flocks: Serology: Serology tests, also known as antibody tests, detect antibodies in blood serum that are produced in response to certain diseases. These tests can identify if birds have been previously exposed to pathogens like avian influenza or Newcastle disease. Microbiology: Microbiological tests identify the presence of bacteria, viruses, parasites or other microorganisms in samples. Culturing and PCR (polymerase chain reaction) techniques are commonly used to detect specific pathogens. Necropsy: A postmortem examination of dead birds, known as a necropsy, can provide visual clues to diagnosis. Tissue samples collected during necropsy can then undergo further lab testing. Molecular Diagnostics: Advanced molecular diagnostic methods like real-time PCR have revolutionized poultry disease detection. They provide rapid, sensitive identification of pathogens from different sample types. Sample Collection and Submission

Proper sample collection and handling is critical for accurate diagnostic results. Samples must be properly stored and transported to avoid deterioration. The most common sample types submitted for poultry diagnostics include: - Oropharyngeal (choanal cleft) and cloacal swabs: Used for microbiological testing. - Serum: Collected from the brachial vein for serology tests. - Tissues: Organ tissues collected during necropsy examinations. - Eggs: Yolk, albumen and embryos can be tested for certain pathogens. - Feces: Help identify enteric (intestinal) infections and coccidiosis. Common Poultry Diseases Tested

Some significant diseases frequently evaluated through poultry diagnostic include: Avian Influenza: A highly contagious viral disease and causative agent of bird flu outbreaks. Rapid PCR tests are commonly used. Marek's Disease: A ubiquitous herpesvirus infection causing tumors. PCR analysis of tissue samples enables diagnosis. Infectious Bronchitis: A coronavirus infecting the respiratory and urogenital tracts. RT-PCR tests are highly sensitive and specific. Newcastle Disease: A devastating viral pathogen affecting many bird species worldwide. Microbiological culturing and molecular tests are used. Salmonellosis: Zoonotic bacterial disease associated with Salmonella enterica. Bacteria is isolated through culture and identified. Coccidiosis: An enteric parasitic disease primarily affecting young chickens and turkeys. Fecal flotation or molecular tests detect oocyst shedding. The Role of Diagnostics in Disease Management

Timely and accurate diagnostics is essential for controlling disease outbreaks and minimizing economic losses in poultry production. Knowing disease status allows for: - Rapid treatment and containment: Prompt diagnosis leads to quicker therapeutic intervention and prevents spread. - Monitoring flock health: Routine monitoring through diagnostics helps detect subclinical infections and implement preventive measures. - Vaccine selection: Diagnostics guides proper vaccine selection to provide protection against significant prevalent pathogens. - Trade and movement: Many countries require diagnostic testing and certification for import/export of poultry and products. - Surveillance programs: Industry-wide surveillance through laboratory submission aids early detection of foreign diseases. In conclusion, modern poultry diagnostics employs a range of laboratory tests tailored to each situation. Strategic use of diagnostics supports optimum flock health, productivity and food safety through early disease identification and management. Diagnostics is an indispensable tool for disease prevention and control in the poultry industry.

[gyaanjyotieducation]

UniQ PathLab: Your Trusted Partner for COVID-19 Testing in Noida

Introduction: In the ongoing battle against the COVID-19 pandemic, testing remains a crucial tool for early detection and containment. Residents of Noida can avail themselves of reliable and efficient testing services at UniQ PathLab. This blog aims to guide you through the process of getting a COVID-19 test in Noida with UniQ PathLab, ensuring your safety and peace of mind.

Understanding the Importance of COVID-19 Testing: COVID-19 testing is vital for identifying and isolating infected individuals to prevent the spread of the virus. Whether you're experiencing symptoms or need a test for travel or workplace requirements, UniQ PathLab offers various testing options to meet your needs.

About Covid Test :

A COVID-19 test is a diagnostic procedure designed to detect the presence of the SARS-CoV-2 virus, which causes the coronavirus disease 2019 (COVID-19). These tests play a crucial role in identifying and isolating individuals who are infected with the virus, helping to control the spread of the disease. There are several types of COVID-19 tests, each serving different purposes:

RT-PCR (Reverse Transcription Polymerase Chain Reaction):

This is the most common and accurate type of COVID-19 test. It detects the genetic material of the virus in a sample collected from the respiratory system (usually through a nasal or throat swab). RT-PCR tests are highly sensitive and can identify the virus even in individuals with low viral loads.

Rapid Antigen Test:

This test identifies specific proteins on the surface of the virus. It provides quicker results compared to RT-PCR, usually within 15-30 minutes. Rapid antigen tests are suitable for quick screening, especially in situations where immediate results are needed.

Antibody Test (Serology Test):

This test detects antibodies produced by the immune system in response to a past infection. It is not used for diagnosing active infections but can indicate whether someone has been previously exposed to the virus. Antibody tests are often used to assess the prevalence of COVID-19 in a population.

The choice of test depends on various factors, including the individual's symptoms, exposure history, and the purpose of testing. RT-PCR remains the gold standard for diagnosing active COVID-19 infections due to its high sensitivity and accuracy.

It's important to note that a negative test result does not guarantee that an individual is not infected, especially if they have been recently exposed. Testing is just one part of a comprehensive strategy that includes other preventive measures such as vaccination, wearing masks, practicing good hand hygiene, and maintaining physical distancing. Individuals should follow public health guidelines and consult healthcare professionals for personalized advice on testing and COVID-19 prevention.

Types of COVID-19 Tests Available:

UniQ PathLab provides different types of COVID-19 tests, including RT-PCR, Rapid Antigen, and Antibody tests. Each test serves a specific purpose, and the choice depends on factors such as symptoms, exposure history, and the urgency of results.

Booking Your Test with UniQ PathLab:

UniQ PathLab has simplified the testing process to make it convenient for residents. You can book your COVID-19 test online through their user-friendly website or contact their customer service for assistance. Walk-in appointments may also be available at their testing centers in Noida.

Testing Centers in Noida: UniQ PathLab operates multiple testing centers across Noida, ensuring accessibility for residents. These centers are equipped with state-of-the-art facilities and follow strict hygiene protocols to maintain a safe testing environment.

Ensuring Safety during Testing: UniQ PathLab prioritizes the safety of individuals during the testing process. Their staff is trained to follow stringent safety measures, including the use of personal protective equipment (PPE), sanitization of equipment, and maintaining social distancing norms.

Receiving Your Test Results: UniQ PathLab understands the importance of timely results. Depending on the type of test, you can expect to receive your results within a specified timeframe. The lab provides digital reports, making it easy for you to access and share your results when needed.

Post-Test Guidance: If your test results indicate a positive diagnosis, UniQ PathLab offers guidance on isolation protocols and steps to take for recovery. Additionally, they may provide information on contacting healthcare professionals for further assistance.

Conclusion: UniQ PathLab in Noida stands as a reliable partner in the community's fight against COVID-19. By following the outlined steps for testing with UniQ PathLab, residents can contribute to breaking the chain of transmission and safeguarding their health and the well-being of others. Stay informed, stay safe!

Frequently Asked Questions (FAQs):

How can I book a COVID-19 test with UniQ PathLab in Noida?

You can easily book a COVID-19 test with UniQ PathLab in Noida by visiting their official website and following the online booking process. Alternatively, you can contact their customer service for assistance or inquire about walk-in appointments at their testing centers.

2. What types of COVID-19 tests does UniQ PathLab offer in Noida?

UniQ PathLab offers a range of COVID-19 tests, including RT-PCR, Rapid Antigen, and Antibody tests. The choice of test depends on factors such as symptoms, exposure history, and the urgency of results.

3.How long does it take to receive COVID-19 test results from UniQ PathLab?

The turnaround time for COVID-19 test results with UniQ PathLab varies depending on the type of test. Generally, RT-PCR results may take a day or two, while Rapid Antigen test results are often available within 15-30 minutes. UniQ PathLab is committed to providing timely results to ensure your peace of mind.

[helloamerican2w]

covid test

Crucial Steps: A Guide to Understanding the COVID Test Process

In the ongoing battle against the global COVID-19 pandemic, testing remains a pivotal tool in identifying and mitigating the spread of the virus. Understanding the COVID test process is crucial for individuals seeking clarity on their health status and for society at large in controlling the transmission of the virus. The COVID test, short for coronavirus test, is a diagnostic examination designed to detect the presence of the SARS-CoV-2 virus, responsible for causing COVID-19. This testing process typically involves the collection of respiratory samples, such as nasopharyngeal swabs, throat swabs, or saliva samples. The collected specimens are then analyzed in specialized laboratories to determine whether the virus is present. One of the most common types of COVID tests is the PCR (polymerase chain reaction) test. This method amplifies genetic material from the virus, allowing for its detection with high sensitivity. PCR tests are known for their accuracy and reliability, making them a preferred choice in diagnosing active COVID-19 infections. The process involves inserting a swab into the back of the throat or the nose to collect a sample for analysis. Another widely used testing method is the rapid antigen test. This test detects specific proteins on the surface of the virus and provides results in a relatively short timeframe. While rapid antigen tests offer quicker results, they may be less sensitive than PCR tests, particularly in individuals with low viral loads. Understanding the COVID test process extends beyond sample collection. Timely and accurate result reporting is essential for effective public health measures. Individuals undergoing testing should be aware of the typical turnaround time for results, which can vary depending on the type of test and the testing facility. It is crucial to follow testing guidelines and any recommended quarantine measures while awaiting results. Testing plays a crucial role not only in diagnosing active infections but also in identifying individuals who may be carrying the virus without exhibiting symptoms. Asymptomatic carriers can unknowingly contribute to the spread of COVID-19, making widespread testing a key strategy in controlling outbreaks. In addition to diagnostic testing, there are also serological tests that detect antibodies produced in response to a previous infection. These tests can provide insights into past exposure to the virus but are not suitable for diagnosing active infections. Serological tests can be valuable in understanding the prevalence of the virus within a community and assessing the potential for herd immunity. In conclusion, comprehending the COVID test process is vital for individuals, communities, and public health systems. Regular and widespread testing contributes to the timely identification of cases, effective contact tracing, and the implementation of appropriate public health measures. By staying informed about the different types of tests available, their purposes, and the importance of result reporting, individuals can actively participate in the collective effort to curb the spread of COVID-19 and protect the well-being of society as a whole.

Navigating Health Safely: Everything You Need to Know About COVID Tests In the ongoing battle against the global COVID-19 pandemic, COVID tests have become an integral tool in understanding and managing the spread of the virus. As individuals and communities strive to navigate health safely, it is essential to be well-informed about the various aspects of COVID testing. A COVID test, or coronavirus test, is a diagnostic procedure aimed at identifying the presence of the SARS-CoV-2 virus, responsible for causing COVID-19. The significance of these tests lies in their ability to detect infections, whether symptomatic or asymptomatic, and to facilitate timely public health interventions. There are several types of COVID tests, each serving specific purposes. The Polymerase Chain Reaction (PCR) test is a widely used method that detects the genetic material of the virus. Known for its high accuracy, the PCR test is effective in diagnosing active infections and is often employed in healthcare settings and testing laboratories. Nasopharyngeal swabs or throat swabs are commonly used to collect samples for PCR testing. Rapid antigen tests are another category of COVID tests designed to provide quick results. These tests detect specific viral proteins and are valuable for immediate screening, especially in high-traffic settings. While rapid antigen tests offer prompt results, they may have lower sensitivity compared to PCR tests, particularly in individuals with lower viral loads. Understanding the COVID test process is crucial for individuals seeking testing. Sample collection methods vary, and individuals may undergo nasal swabs, throat swabs, or even provide saliva samples, depending on the type of test and testing facility. It is important to follow testing guidelines and any recommended quarantine measures while awaiting results. Testing is not limited to diagnosing active infections. Serological tests, also known as antibody tests, are conducted to detect antibodies produced in response to a past infection. These tests contribute to understanding the prevalence of the virus within a community and assessing potential immunity. Timely result reporting is a key component of the testing process. Individuals should be aware of the typical turnaround time for results, which can vary based on the type of test and testing facility. Adhering to recommended quarantine measures during the waiting period is essential for preventing further transmission. Regular and widespread testing is a cornerstone of public health strategies to control the spread of COVID-19. Testing facilitates early identification of cases, effective contact tracing, and the implementation of targeted interventions. By staying informed about the different types of tests available, their purposes, and the importance of result reporting, individuals can actively contribute to the collective effort to navigate health safely and curb the spread of COVID-19 in their communities.

What test should I get to see if I have COVID 19 Navigating Uncertainty: What Test Should I Get to Determine COVID-19 Status? In the current landscape of the ongoing COVID-19 pandemic, individuals find themselves facing uncertainties regarding the most suitable test to determine their COVID-19 status. The question echoes in the minds of many: What test should I get to see if I have COVID-19? Navigating through the array of testing options requires a comprehensive understanding of the available tests and their distinct characteristics. One of the primary tests employed to diagnose active COVID-19 infections is the Polymerase Chain Reaction (PCR) test. This molecular diagnostic test detects the genetic material of the SARS-CoV-2 virus and is renowned for its high accuracy. If you are seeking confirmation of a current infection, the PCR test is a reliable choice. It typically involves the collection of nasopharyngeal or throat swab samples, and the results are obtained through laboratory analysis. For those who prioritize swift results, the rapid antigen test offers a quicker turnaround time compared to the PCR test. Rapid antigen tests detect specific proteins on the surface of the virus and are suitable for immediate screening. However, it is essential to note that these tests may have lower sensitivity, particularly in individuals with lower viral loads. If time is of the essence and you need quick results, the rapid antigen test may be a suitable option. Navigating uncertainty also involves considering serological tests, commonly known as antibody tests. These tests do not diagnose active infections but rather detect the presence of antibodies produced in response to a past infection. If you are curious about whether you have been previously exposed to the virus and developed an immune response, an antibody test may provide valuable insights. Choosing the right test depends on various factors, including the presence of symptoms, the urgency of results, and the purpose of testing. If you are experiencing symptoms associated with COVID-19, such as fever, cough, or shortness of breath, a PCR test is recommended for accurate diagnosis. On the other hand, if you require rapid results for immediate decision-making, a rapid antigen test may be more suitable. It is crucial to adhere to testing guidelines and follow any recommendations from healthcare professionals or testing facilities. Timely result reporting is vital not only for personal decision-making but also for contributing to public health efforts in controlling the spread of the virus. Individuals should be aware of the typical turnaround time for results based on the chosen test. In conclusion, navigating uncertainty about COVID-19 status involves making informed decisions about the type of test to undergo. Whether opting for the precision of a PCR test, the speed of a rapid antigen test, or the insights from an antibody test, individuals play a crucial role in the collective effort to curb the spread of the virus. By understanding the nuances of each test and considering individual circumstances, individuals can make informed choices to safeguard their health and contribute to the broader public health goals.

Choosing Wisely: A Guide to Selecting the Right Test for COVID-19 Detection In the ongoing battle against the global COVID-19 pandemic, the importance of selecting the right test for accurate detection cannot be overstated. Individuals are often confronted with the question: What test should I get to see if I have COVID-19? Navigating through the myriad of testing options requires careful consideration and an understanding of the distinct features of each test. One of the primary tests recommended for COVID-19 detection is the Polymerase Chain Reaction (PCR) test. Renowned for its high accuracy, the PCR test detects the genetic material of the SARS-CoV-2 virus, providing a reliable diagnosis of active infections. Typically, nasopharyngeal or throat swab samples are collected, and the results are obtained through thorough laboratory analysis. If precision in diagnosis is a priority, the PCR test is a prudent choice. For those seeking rapid results, the rapid antigen test emerges as an alternative. This test detects specific viral proteins and offers quicker turnaround times compared to the PCR test. However, it is essential to note that the rapid antigen test may have lower sensitivity, particularly in individuals with lower viral loads. If immediate results are crucial for decision-making, the rapid antigen test may be a suitable option. Adding another dimension to the testing landscape are serological tests, commonly known as antibody tests. Unlike diagnostic tests, antibody tests do not identify active infections but instead detect the presence of antibodies developed in response to a past infection. If the goal is to understand past exposure and potential immunity, an antibody test may provide valuable insights. Choosing the right test depends on various factors, including symptoms, the urgency of results, and the purpose of testing. If an individual is symptomatic with signs of COVID-19, such as fever, cough, or shortness of breath, opting for a PCR test is advisable to ensure accurate diagnosis. Conversely, if rapid results are needed for immediate decision-making, the rapid antigen test may be more suitable. Adhering to testing guidelines and following recommendations from healthcare professionals or testing facilities is crucial. Additionally, being aware of the typical turnaround time for results based on the chosen test is essential for planning and taking appropriate actions while awaiting results. In conclusion, the process of choosing the right test for COVID-19 detection involves a thoughtful evaluation of individual circumstances and testing priorities. Whether prioritizing accuracy with a PCR test, speed with a rapid antigen test, or insights into past exposure with an antibody test, individuals play a crucial role in the collective effort to curb the spread of the virus. By making informed decisions about testing options, individuals contribute not only to their personal well-being but also to the broader public health goals aimed at controlling and mitigating the impact of the COVID-19 pandemic.

Hello american hello american - Your Magazine: Famous News, Lifestyle, Health, Technology, Career & fun etc News: "Welcome to Hello American's News Hub, where stories unfold and perspectives converge. Stay informed with our diverse coverage of national and global events, providing in-depth analyses, breaking news, and thought-provoking insights that shape our world."

Health: "Hello American Health: Your Wellness Compass. Discover a wealth of health resources, expert advice, and articles dedicated to promoting holistic well-being. From fitness trends to mental health guides, we're committed to empowering you on your journey to a healthier life."

Lifestyle: "Experience the Vibrant hello american Lifestyle. Delve into our curated collection celebrating the rich tapestry of American living. Explore travel destinations, culinary delights, fashion trends, and more, embracing the diverse threads that weave the fabric of our culture."

Technology: "Hello American Tech: Navigating Tomorrow's Innovations. Explore the forefront of technology with us. From gadget reviews to AI breakthroughs, our tech section unveils the latest trends, helping you stay connected and empowered in an ever-evolving digital landscape."

Career: "Hello American Careers: Empowering Your Professional Odyssey. Embark on a journey of growth and opportunities. Access career insights, job openings, mentorship programs, and skill development resources, designed to fuel your aspirations and drive your career forward."

Education: "Education Redefined at Hello American. Embrace learning as an ongoing adventure. Dive into our educational hub, where traditional knowledge meets innovative approaches. Explore diverse learning paths, online courses, and resources designed to inspire lifelong curiosity and growth."

Each section offers a tailored experience, catering to the diverse interests and needs of the Hello American audience, while aiming to provide valuable information and resources in these respective domains.